AVISE CB CAPS
Dead / Abandoned — Abandoned — no statement of use filed (as of 21 Sept 2015)
What this means for you
This application is over — abandoned 21 Sept 2015. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85398302
- Mark type
- Stylized text
- Filed
- 15 Aug 2011
- Published for opposition
- 24 Dec 2013
- Abandoned
- 21 Sept 2015
- Attorney of record
- David Harper
Goods and services
- Class 042 — Scientific and technological services: Medical and clinical chemical laboratory services used by medical professionals for systemic lupus erythematosus diagnosis, disease stratification, prognosis, therapy selection and therapy monitoring; medical laboratory services for detecting, providing prognosis and monitoring systemic lupus erythematosus disease in patients; medical laboratory services and clinical laboratory research in the field of early prediction algorithms that incorporate both clinical and laboratory parameters and assists in the monitoring, predicting and diagnosing of individuals who are likely to develop systemic lupus erythematosus
Owner
- Exagen Diagnostics, Inc., Albuquerque, NM, US
- Exagen Diagnostics, Inc., Albuquerque, NM, US
Prior registrations
Prosecution history
- 21 Sept 2015 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 21 Sept 2015 — ABANDONMENT - NO USE STATEMENT FILED
- 27 Feb 2015 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Feb 2015 — SOU EXTENSION 2 GRANTED
- 16 Feb 2015 — SOU EXTENSION 2 FILED
- 16 Feb 2015 — SOU TEAS EXTENSION RECEIVED
- 10 Sept 2014 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Sept 2014 — SOU EXTENSION 1 GRANTED
- 15 Aug 2014 — SOU EXTENSION 1 FILED
- 05 Sept 2014 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 15 Aug 2014 — SOU TEAS EXTENSION RECEIVED
- 18 Feb 2014 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 24 Dec 2013 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Dec 2013 — PUBLISHED FOR OPPOSITION
- 04 Dec 2013 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED